Skip to content
Clinical Trials – home
Research site

ID Clinic Arkadiusz Pisula

Poland Ul. Janowska 19, 41-400 Myslowice, Poland

  • 1 trial recruiting
  • Alpha-1 antitrypsin deficiency · Hepatic encephalopathy · Primary biliary cholangitis
  • Adult patients

About Specializations

ID Clinic Arkadiusz Pisula in Myslowice, Poland specialises in clinical trials of conditions such as Alpha-1 antitrypsin deficiency, Hepatic encephalopathy, Primary biliary cholangitis, Cholestatic pruritus, and other specialisations. This site conducts important research.

Main research areas of the site

Cholestasis and Pruritus Research

The clinic is evaluating the safety and tolerability of a new therapy for cholestatic pruritus in patients with primary biliary cholangitis, aiming to improve symptom control.

  • Long‑term safety monitoring
  • Assessment of itch reduction
  • Quality‑of‑life outcomes

Conducted at ID Clinic Arkadiusz Pisula in Myslowice, Poland, the study involves two investigators and contributes to advances in Digestive System Diseases.

Hepatic Encephalopathy Prevention Study

Researchers are testing a soluble rifaximin formulation to delay hospitalisation caused by hepatic encephalopathy in individuals with cirrhosis, focusing on treatment effectiveness.

  • Comparison with placebo
  • Reduction in encephalopathy episodes
  • Safety and tolerability assessment

This trial aims to enhance management strategies for advanced liver disease and improve patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Janowska 1941-400 MyslowicePoland
Recruiting now
1 trial
Conditions studied
4

More sites in MyslowicePoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

3 clinical trials

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Fazirsiran
  • Sponsor:Takeda Development Center Americas Inc.
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Rifaximin
  • Sponsor:Salix Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Linerixibat
  • Sponsor:Glaxosmithkline Research & Development Limited
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.